Traditional Chinese medicinal composition for treating prostatoplasia

Abstract

The invention discloses a traditional Chinese medicinal composition for treating prostatoplasia. The composition comprises, by weight, 10-30 parts of Manyprickle Acathopanax Root, 10-20 parts of Cogongrass rhizome, 5-15 parts of turtle shell, 10-20 parts of mantis egg-case, 10-20 parts of semen cuscutae, 10-20 parts of Chinese ilex, 10-20 parts of Hedyotis diffusa, 5-15 parts of algae, 10-20 parts of Rubia cordifolia, 10-20 parts of Rhizoma Polygoni Cuspidati, 10-20 parts of corn silk, 10-20 parts of Cyrtomium fortunei, 5-15 parts of Flos Inulae, 10-20 parts of Herba Houttuyniae, 10-20 parts of Radix Morindae officinalis, 10-20 parts of loofah sponge, 10-20 parts of Radix Codonopsis, 5-15 parts of reed rhizome, 10-20 parts of Vaccaria segetalis, 10-20 parts of Amur Corktree Bark, 5-15 parts of cattail pollen and 10-20 parts of cinnamon. The traditional Chinese medicinal composition has the efficacy of tonifying kidney and invigorating spleen, clearing heat and promoting urination, freeing yang and expelling stasis, and warming yang for diuresis, has a substantial treatment effect on prostatoplasia, has reliable effects, and has no toxic or side effects.

Description

technical field [0001] The invention relates to a medical preparation of undetermined structure of traditional herbal medicine, especially a traditional Chinese medicine composition for treating hyperplasia of prostate. Background technique [0002] Prostatic hyperplasia, formerly known as prostatic hypertrophy, is one of the common diseases of elderly men. It is a benign lesion of the prostate gland. Early symptoms include frequent urination, urgency, and nocturia. With the obstruction of the proliferating prostate, there may be inability to urinate, thinning of the urinary stream, and dribbling. The obstruction continues to develop, and the prostate blood vessels will rupture under the condition of increased pressure, making the blood in the urine that is hematuria. Therefore, benign prostatic hyperplasia should be treated in time. At present, surgical treatment is generally used in the clinical treatment of benign prostatic hyperplasia, but the risk is high and the cos...

AI Technical Summary

Problems solved by technology

At present, surgical treatment is generally used in the clinical treatment of benign prostatic hyperplasia, but the risk is high and the cost is high; drugs can also be used for treatment, such as hormones or anti-hormonal drugs, α-adrenergic receptor blockers, 5α-receptor reductase Inhibitors, cholesterol inhibitors and other drugs, but drug treatment has large side effects and is prone to dependence. After long-term use, it will cause great harm to the cardiovascular and cerebrovascular system and immune system, and it is mainly to improve and relieve symptoms, not to cure Benign prostatic hyperplasia